Healio Gastroenterology


The following articles appeared in the print edition of HEALIO GASTROENTEROLOGY.

Table of Contents
By the Numbers

10 Recent Advances in Crohn’s and Colitis Research

Cover Story

Point-of-care HCV Assays: A Turning Point for Decentralized Diagnosis

Drug Pipeline

FDA Approves Xeljanz for Moderate-to-Severe UC


Flexibility Key in Diagnosing, Managing IBS

Edward V. Loftus Jr., MD, AGAF, FACG, FACP


AASLD Online HCV Guide Update Includes Key At-risk Populations

Healio Hot Topic

Why a GI Dietitian Adds Value to a GI Practice

Kate Scarlata, RDN

IBS: Transitioning from a Syndrome to a Disease

William Chey, MD, AGAF, FACG

GI psychologists bring value to IBS patient care

9 Things to Know About Medical Therapies for IBS

In the Journals

Colon Cancer Risk Depends on Polyp Type Found During Colonoscopy

Gut Microbiome Linked to Artery Health

Drinking Sweetened Beverages Does Not Appear to Increase IBD Risk

Rare Skin Condition Linked to Crohn’s Disease

Meeting News

New Drug May Protect Celiac Patients From Inadvertent Gluten Exposure

Most Who Avoid Gluten Lack Symptoms of Intolerance, Sensitivity

Microbiome Therapy Induces Remission in Mild-to-moderate UC

Novel Questionnaire May Help Assess Quality of Life in IBD

Genomic Marker Linked to Lynch Syndrome Across Cancer Types

Low Vitamin D Levels Appear to Follow, Not Cause, Crohn’s Disease

Antacid, Aspirin Combination Slows Disease Progression in Barrett’s Esophagus

Trend Watch

GI Leader to Expand Specialty Medical Home Care Model

$2.4 Million Grant to Fund Trial Comparing IBD Therapies

FDA Warns 53 Websites to Stop Marketing Illegal Opioids

AGA Working Group to Address Myths About IBD, Pregnancy